HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 201 filers reported holding HORIZON PHARMA PLC in Q1 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $94,000 | +54.1% | 3,576 | +15.0% | 0.00% | – |
Q4 2018 | $61,000 | -6.2% | 3,109 | -6.0% | 0.00% | – |
Q3 2018 | $65,000 | +35.4% | 3,306 | +16.1% | 0.00% | – |
Q2 2018 | $48,000 | +182.4% | 2,848 | +134.8% | 0.00% | – |
Q1 2018 | $17,000 | 0.0% | 1,213 | +8.3% | 0.00% | – |
Q4 2017 | $17,000 | +30.8% | 1,120 | +12.0% | 0.00% | – |
Q3 2017 | $13,000 | +8.3% | 1,000 | 0.0% | 0.00% | – |
Q2 2017 | $12,000 | -20.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2017 | $15,000 | -6.2% | 1,000 | -3.3% | 0.00% | – |
Q4 2016 | $16,000 | -99.3% | 1,034 | -99.1% | 0.00% | -100.0% |
Q3 2016 | $2,141,000 | +21.5% | 118,096 | +10.4% | 0.00% | 0.0% |
Q2 2016 | $1,762,000 | +6192.9% | 106,949 | +6136.1% | 0.00% | – |
Q1 2016 | $28,000 | -94.6% | 1,715 | -92.8% | 0.00% | -100.0% |
Q4 2015 | $518,000 | +47.2% | 23,868 | +34.2% | 0.00% | – |
Q3 2015 | $352,000 | -12.4% | 17,785 | +53.8% | 0.00% | – |
Q2 2015 | $402,000 | +48.9% | 11,561 | +11.4% | 0.00% | – |
Q1 2015 | $270,000 | +154.7% | 10,381 | +25.8% | 0.00% | – |
Q4 2014 | $106,000 | – | 8,254 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JABODON PT CO | 187,808 | $4,519,000 | 3.52% |
KNOTT DAVID M | 50,046 | $1,204,000 | 0.51% |
CASTLEARK MANAGEMENT LLC | 362,980 | $8,733,000 | 0.34% |
EAGLE ASSET MANAGEMENT INC | 2,692,100 | $64,771,000 | 0.33% |
USA FINANCIAL FORMULAS | 15,202 | $402,000 | 0.20% |
Qtron Investments LLC | 12,274 | $295,000 | 0.18% |
C WorldWide Group Holding A/S | 491,544 | $11,827,000 | 0.15% |
Gotham Asset Management, LLC | 207,158 | $4,984,000 | 0.08% |
Russell Investments Group, Ltd. | 608,977 | $14,652,000 | 0.03% |
FNY Investment Advisers, LLC | 3,350 | $80,000 | 0.02% |